These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20185633)

  • 1. Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.
    Esler M; Lambert E; Schlaich M
    J Appl Physiol (1985); 2010 Dec; 109(6):1996-8; discussion 2016. PubMed ID: 20185633
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.
    Negrao CE; Negrao MV
    J Appl Physiol (1985); 2010 Dec; 109(6):2006. PubMed ID: 21188817
    [No Abstract]   [Full Text] [Related]  

  • 3. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
    Rohrwasser A
    J Appl Physiol (1985); 2010 Dec; 109(6):2007. PubMed ID: 21188818
    [No Abstract]   [Full Text] [Related]  

  • 4. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Sympathetic nervous system, plasma volume, and hypertension.
    Christensen NJ
    J Appl Physiol (1985); 2010 Dec; 109(6):2003. PubMed ID: 21188813
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Dominant contributors for systemic hypertension--who leads, who follows?
    Braga VA
    J Appl Physiol (1985); 2010 Dec; 109(6):2007-8. PubMed ID: 21188840
    [No Abstract]   [Full Text] [Related]  

  • 6. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Chronic activation of sympathetic nervous system and systemic hypertension--stress shows the way.
    Fontes MA; Xavier CH
    J Appl Physiol (1985); 2010 Dec; 109(6):2004-5. PubMed ID: 21188815
    [No Abstract]   [Full Text] [Related]  

  • 7. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
    Cohn JN
    J Appl Physiol (1985); 2010 Dec; 109(6):2006-7. PubMed ID: 21188834
    [No Abstract]   [Full Text] [Related]  

  • 8. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Systemic hypertension--a "ratologist" point of view.
    Julien C
    J Appl Physiol (1985); 2010 Dec; 109(6):2004. PubMed ID: 21188799
    [No Abstract]   [Full Text] [Related]  

  • 9. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correlated with high blood pressure in humans.
    Kobori H; Fu Q; Crowley SD; Gonzalez-Villalobos RA; Campos RR
    J Appl Physiol (1985); 2010 Dec; 109(6):2003. PubMed ID: 21148352
    [No Abstract]   [Full Text] [Related]  

  • 10. Rebuttal from Navar.
    Navar LG
    J Appl Physiol (1985); 2010 Dec; 109(6):2001-2. PubMed ID: 21148351
    [No Abstract]   [Full Text] [Related]  

  • 11. Rebuttal from Esler, Lambert, and Schlaich.
    Esler M; Lambert E; Schlaich M
    J Appl Physiol (1985); 2010 Dec; 109(6):2000-1. PubMed ID: 21148350
    [No Abstract]   [Full Text] [Related]  

  • 12. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Systemic hypertension--involvement of the CNS to this complex puzzle.
    Moreira TS; Takakura AC; Antunes VR
    J Appl Physiol (1985); 2010 Dec; 109(6):2004. PubMed ID: 21188814
    [No Abstract]   [Full Text] [Related]  

  • 13. Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension.
    Navar LG
    J Appl Physiol (1985); 2010 Dec; 109(6):1998-2000; discussion 2015. PubMed ID: 21148349
    [No Abstract]   [Full Text] [Related]  

  • 14. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. AT1 receptors in the kidney mediate the chronic hypertensive response to angiotensin II.
    Crowley SD
    J Appl Physiol (1985); 2010 Dec; 109(6):2012-3. PubMed ID: 21188828
    [No Abstract]   [Full Text] [Related]  

  • 15. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Intrarenal angiotensin II generation as a hypertensinogenic mechanism.
    Gonzalez-Villalobos RA; Fuchs S
    J Appl Physiol (1985); 2010 Dec; 109(6):2013. PubMed ID: 21188829
    [No Abstract]   [Full Text] [Related]  

  • 16. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Sympathetic activation is the dominant contributor to systemic hypertension.
    Fu Q; Levine BD
    J Appl Physiol (1985); 2010 Dec; 109(6):2012. PubMed ID: 21188802
    [No Abstract]   [Full Text] [Related]  

  • 17. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Obesity: a common prime mover of chronic activation of the sympathetic nervous system and the renin-angiotensin system in systemic hypertension?
    Szelényi Z
    J Appl Physiol (1985); 2010 Dec; 109(6):2008-9. PubMed ID: 21188835
    [No Abstract]   [Full Text] [Related]  

  • 18. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
    Li P
    J Appl Physiol (1985); 2010 Dec; 109(6):2008. PubMed ID: 21188819
    [No Abstract]   [Full Text] [Related]  

  • 19. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Sympathetic activation: cause or consequence of hypertension?
    Campos RR; Bergamaschi CT
    J Appl Physiol (1985); 2010 Dec; 109(6):2013-4. PubMed ID: 21188830
    [No Abstract]   [Full Text] [Related]  

  • 20. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
    Goldstein DS
    J Appl Physiol (1985); 2010 Dec; 109(6):2005-6. PubMed ID: 21188816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.